Jinwook Kim, CEO of MetaDx, presenting at the 5th IR Day hosted by the Pet Industry Development Council on October 23 in Seongnam City, Gyeonggi Province. [Photo Credit: News1]
The 5th IR (Investor Relations) Day, organized by the Pet Industry Development Council, took place on October 23 at 3 PM at the Pangyo Startup Campus in Seongnam City.
This event featured participation from MetaDx, a startup developing digital transformation technology for veterinary hospital processes, and REV-MED, a biomedical company focusing on innovative medical technologies for disease treatment and life extension.
MetaDx has developed software that detects organic substances in blood to analyze biomarkers, enabling the identification and assessment of tumors, including their malignancy. The company is working to integrate artificial intelligence into veterinary medicine, aiming to standardize diagnostic and monitoring capabilities across veterinary hospitals, regardless of size.
Recently, MetaDx developed an automated diagnostic support solution based on veterinary biometric information analysis technology. This solution provides higher accuracy by standardizing and correcting data from pet patients.
Jinwook Kim, CEO of MetaDx, stated, “Currently, there is no practical disease screening solution available for use in veterinary hospitals. The lack of automated medical data solutions in the veterinary field has led to conflicts between veterinarians and pet owners, which motivated us to develop this product.”
He added, “Our goal is to become a leader in veterinary AI solutions and to pioneer new markets by expanding the indications of our core technology.”
REV-MED, on the other hand, is a biomedical company advancing autologous stem cell therapy through its easy-to-use kits that extract and concentrate specific cells. The company owns NovaStem technology, which separates and concentrates stem cells from bone marrow.
Using this technology, REV-MED has introduced products that extract growth factors and mesenchymal stem cells (MSCs) from blood, bone marrow, and adipose tissue, focusing on cell regeneration.
Clinical trials have shown the effectiveness of these products in treating conditions such as hair loss, early-stage arthritis, cartilage regeneration, and wound healing.
Edward BG Shin, CEO of REV-MED, stated, “When developing products for human treatments, we often validate them through animal testing. Treating humans and animals isn’t fundamentally different, so we aim to realize the dream of extending healthy lifespans in the pet healthcare market.”
The Pet Industry Development Council, which hosted the event, was launched in February to support the discovery and growth of startups and their entry into overseas markets. Its members include the Korean Veterinary Medical Association, the Global Digital Innovation Network (GDIN), Hana Bank, and the Haemaru Animal Medical Foundation.
Since its launch, the council has held IR Day events on the third Friday of each month for pet-related companies. In July, it also organized a meeting with the Ministry of Economy and Finance to discuss field opinions necessary for fostering the pet industry.
Source: https://www.mk.co.kr/news/it/11101366
Jinwook Kim, CEO of MetaDx, presenting at the 5th IR Day hosted by the Pet Industry Development Council on October 23 in Seongnam City, Gyeonggi Province. [Photo Credit: News1]
The 5th IR (Investor Relations) Day, organized by the Pet Industry Development Council, took place on October 23 at 3 PM at the Pangyo Startup Campus in Seongnam City.
This event featured participation from MetaDx, a startup developing digital transformation technology for veterinary hospital processes, and REV-MED, a biomedical company focusing on innovative medical technologies for disease treatment and life extension.
MetaDx has developed software that detects organic substances in blood to analyze biomarkers, enabling the identification and assessment of tumors, including their malignancy. The company is working to integrate artificial intelligence into veterinary medicine, aiming to standardize diagnostic and monitoring capabilities across veterinary hospitals, regardless of size.
Recently, MetaDx developed an automated diagnostic support solution based on veterinary biometric information analysis technology. This solution provides higher accuracy by standardizing and correcting data from pet patients.
Jinwook Kim, CEO of MetaDx, stated, “Currently, there is no practical disease screening solution available for use in veterinary hospitals. The lack of automated medical data solutions in the veterinary field has led to conflicts between veterinarians and pet owners, which motivated us to develop this product.”
He added, “Our goal is to become a leader in veterinary AI solutions and to pioneer new markets by expanding the indications of our core technology.”
REV-MED, on the other hand, is a biomedical company advancing autologous stem cell therapy through its easy-to-use kits that extract and concentrate specific cells. The company owns NovaStem technology, which separates and concentrates stem cells from bone marrow.
Using this technology, REV-MED has introduced products that extract growth factors and mesenchymal stem cells (MSCs) from blood, bone marrow, and adipose tissue, focusing on cell regeneration.
Clinical trials have shown the effectiveness of these products in treating conditions such as hair loss, early-stage arthritis, cartilage regeneration, and wound healing.
Edward BG Shin, CEO of REV-MED, stated, “When developing products for human treatments, we often validate them through animal testing. Treating humans and animals isn’t fundamentally different, so we aim to realize the dream of extending healthy lifespans in the pet healthcare market.”
The Pet Industry Development Council, which hosted the event, was launched in February to support the discovery and growth of startups and their entry into overseas markets. Its members include the Korean Veterinary Medical Association, the Global Digital Innovation Network (GDIN), Hana Bank, and the Haemaru Animal Medical Foundation.
Since its launch, the council has held IR Day events on the third Friday of each month for pet-related companies. In July, it also organized a meeting with the Ministry of Economy and Finance to discuss field opinions necessary for fostering the pet industry.
Source: https://www.mk.co.kr/news/it/11101366